arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BICYCLE THERAPEUTICS PLC

BCYC

$3.60 ▼ -0.12 (-3.36%) at close

10 Visible periods

33 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

BICYCLE THERAPEUTICS PLC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $249.4M

Dividend Yield —

Revenue Growth 105.8% ↗

Op. Margin -340.4%

ROIC -40.5% ↘

FCF / Share $-3.64 ↘

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$72.59M

↑ +105.8% —

Net Income Profit after all expenses

$-218.96M

↓ -29.5% —

Operating Margin Operating profit as % of sales

-340.4%

↓ -78.6% 0th

FCF / Share Free cash flow per share

$-3.64

↓ -27.6% —

Long-Term Debt Long-term obligations

$30.70M

↑ +1.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2016

FY 2017

FY 2018

FY 2019

FY 2020

FY 2021

$0.00

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	105.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1222%)	30.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+285%)	86.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+981%)	23.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+196%)	12.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+57%)	-24.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-409%)	93.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1067%)	246.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2980%)	—	—
EPS Growth YoY (%)	-9.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	42.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-33.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-42.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-0.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-29.5% Weak ↑ Weak Improving Year-over-year change in net income	6.4% Fair ↑ Fair Improving Year-over-year change in net income	-60.3% Weak ↓ Weak Declining Year-over-year change in net income	-68.7% Weak ↓ Weak Declining Year-over-year change in net income	-31.0% Weak ↑ Weak Improving Year-over-year change in net income	-66.7% Weak ↓ Weak Declining Year-over-year change in net income	-40.1% Weak Weak Year-over-year change in net income	-34.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-27.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	-59.7% Weak ↑ Weak Improving Year-over-year change in free cash flow	49.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-427.8% Weak Weak Year-over-year change in free cash flow	32.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	71.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	44.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	37.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	1.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	17.9% Excellent Excellent Compound annual revenue growth over 3 years	71.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	47.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	20.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	30.5% Excellent Excellent Compound annual revenue growth over 5 years	47.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-340.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2369%)	—	—	—	—	—	-190.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1370%)	-304.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2132%)	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-301.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2614%)	-479.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4093%)	—	—	—	-491.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4191%)	-221.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1948%)	-306.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2651%)	—	—
FCF Margin (%) (%)	-347.2% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-470.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-235.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-143.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-182.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-218.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-382.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-122.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.25x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-40.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	30.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	34.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-34.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-26.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-35.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-339%)	-21.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-48.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-425%)	-41.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-378%)	-19.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	-53.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-456%)	-32.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	31.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+109%)	34.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+130%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	—	0.08x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.11x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	0.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	—	—	—	—
Interest Coverage (x)	—	-152.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-58.21x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-34.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	-113.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-628.11M	$-879.52M	$-495.73M	$-308.84M	$-408.81M	$14.51M	$0.00	$0.00	—	—
Debt / EBITDA (x)	—	—	-0.17x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.27x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$1.05	$0.61	$0.76	$0.49	$0.47	$0.54	—	—	—	—
Basic EPS, GAAP (USD)	$-3.16	$-2.90	$-5.08	$-3.80	$-2.67	$-2.66	—	—	—	—
Free Cash Flow per Share (USD)	$-3.64	$-2.85	$-1.79	$-3.54	$-0.67	$-0.99	—	—	—	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—
Book Value per Share (USD)	$8.79	$11.48	$8.74	$9.06	$11.71	$4.53	$5.18	$-85.70	—	—
Tangible Book Value per Share (USD)	$8.79	$11.48	$8.74	$9.06	$11.71	$4.53	$5.18	$-85.70	—	—
Basic Weighted Avg Shares (shares)	69.28M	58.21M	35.59M	29.66M	25.06M	19.15M	—	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$625.90M	$861.38M	$492.33M	$316.04M	$422.32M	$132.59M	$95.33M	$67.84M	—	—
LT Debt (USD)	—	—	$30.70M	$30.32M	$29.87M	$14.51M	—	—	—	—
Total Equity (USD)	$609.98M	$793.06M	$370.93M	$270.78M	$346.25M	$95.46M	$93.20M	$-69.83M	$-47.18M	$-33.80M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$72.59M	$35.27M	$26.98M	$14.46M	$11.70M	$10.39M	$13.80M	$7.14M	$2.06M	—
Depreciation Expense (USD)	$6.42M	$7.17M	$6.55M	$3.69M	$1.41M	$1.28M	$960.00K	$712.00K	$332.00K	—
Net Income, GAAP (USD)	$-218.96M	$-169.03M	$-180.66M	$-112.72M	$-66.82M	$-51.01M	$-30.61M	$-21.85M	$-16.26M	—
Operating Cash Flow (USD)	$-249.68M	$-164.72M	$-60.63M	$-86.11M	$-14.79M	$-17.79M	$-28.61M	$-26.08M	$-1.42M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 36 quarters

BICYCLE THERAPEUTICS PLC

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BCYC with peers